Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer

NCT00738777 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

250

Enrollment

OTHER

Sponsor class

Stopped in preparation for an amendment

Conditions

Breast Cancer

Interventions

DRUG: Anastrozole
DRUG: Anastrozole+Fulvestrant
DRUG: Tamoxifen
DRUG: Tamoxifen

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]